Wednesday, 19 June 2013

Observation is safe, cost-saving in low-risk prostate cancer

Many men with low-risk, localized prostate cancers can safely choose active surveillance or “watchful waiting” instead of undergoing immediate treatment and have better quality of life while reducing health care costs, according to a study by researchers at Dana-Farber Cancer Institute and Massachusetts General Hospital. Read more here.

Study mentioned: Hayes JH et al. Observation versus initial treatment for men with localized, low-risk prostate cander: A cost-effectiveness analysis. Ann Intern Med. 2013;158(12):853-860. doi:10.7326/0003-4819-158-12-201306180-00002

No comments:

Post a Comment